Alexandra Hebar Selected Research

pyrazine-2-carboxylic acid N'- (7- fluoropyrrolo(1,2- a)quinoxalin- 4- yl)- hydrazide

1/2012

NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandra Hebar Research Topics

Disease

3	Neoplasms (Cancer) 01/2013 - 01/2012
1	Colonic Neoplasms (Colon Cancer) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Infections 09/2010

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2013 - 01/2012
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2015
1	AC133 AntigenIBA 01/2015
1	Codon (Codons)IBA 01/2012
1	arginylarginine (Arg-Arg)IBA 01/2012
1	prolyl-proline (Pro-Pro)IBA 01/2012
1	pyrazine-2-carboxylic acid N'- (7- fluoropyrrolo(1,2- a)quinoxalin- 4- yl)- hydrazideIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	pyrrolidine dithiocarbamic acidIBA 09/2010
1	prolinedithiocarbamate (PDTC)IBA 09/2010